Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Nov 2023, 17:07:01 UTC
Next SEC filing
01 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 21 Nov 2023.

Key facts

  • This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Nov 2023, 17:07.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$248,298.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Gift

Transaction value
$0
Shares
-350
Change %
-1.2%
Price
$0.000000
Shares after
28,710
Date
01 Mar 2021
Ownership
Direct
Footnotes
F1
CRL transaction

Common Stock

Purchase

Transaction value
$248,298
Shares
+1,322
Change %
+3.1%
Price
$187.82
Shares after
44,449
Date
20 Nov 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The total in column 5 reflects the ownership as of the date of the transaction.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .